HomeMLTX • NASDAQ
MoonLake Immunotherapeutics
add
$43.50
1.16%
After Hours:(0.00%)0.00
$43.50
Closed: Jun 18, 4:02:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 47.49M | 139.58% |
Net income | -39.94M | -192.14% |
Net profit margin | — | — |
Earnings per share | -0.63 | -186.36% |
EBITDA | -47.11M | -141.67% |
Effective tax rate | -0.38% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 480.13M | -12.23% |
Total assets | 511.26M | -9.37% |
Total liabilities | 98.68M | 741.22% |
Total equity | 412.58M | — |
Shares outstanding | 63.47M | — |
Price to book | 6.70 | — |
Return on assets | -24.00% | — |
Return on capital | -25.14% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -39.94M | -192.14% |
Cash from operations | -38.14M | -155.15% |
Cash from investing | 56.25M | 295.27% |
Cash from financing | 73.12M | 43.44% |
Net change in cash | 91.14M | 1,153.30% |
Free cash flow | -25.47M | -68.33% |
Previous close
$43.00
Day range
$42.93 - $44.20
Year range
$31.42 - $58.26
Market cap
2.79B USD
Avg Volume
572.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2020
Headquarters
Website
Employees
100
